Integer (NYSE:ITGR) Sets New 52-Week Low - What's Next?

Integer Holdings Co. (NYSE:ITGR - Get Free Report)'s share price reached a new 52-week low during trading on Tuesday . The company traded as low as $104.93 and last traded at $106.39, with a volume of 903865 shares. The stock had previously closed at $112.93.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on the company. Truist Financial dropped their price objective on Integer from $163.00 to $140.00 and set a "buy" rating for the company in a report on Friday. Benchmark upped their price objective on shares of Integer from $140.00 to $150.00 and gave the stock a "buy" rating in a research report on Friday, February 21st. KeyCorp raised their target price on shares of Integer from $144.00 to $154.00 and gave the company an "overweight" rating in a report on Friday, January 24th. Raymond James initiated coverage on shares of Integer in a research report on Friday, March 28th. They issued an "outperform" rating and a $145.00 target price for the company. Finally, Oppenheimer lowered shares of Integer from an "outperform" rating to a "market perform" rating in a research report on Friday, February 21st. Two investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat.com, Integer currently has an average rating of "Moderate Buy" and an average price target of $146.00.

Integer Stock Performance

The company's 50 day moving average is $123.88 and its 200 day moving average is $130.93. The firm has a market cap of $4.06 billion, a P/E ratio of 34.67, a P/E/G ratio of 1.72 and a beta of 1.09. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.09 and a current ratio of 2.95.

Remove Ads

Integer (NYSE:ITGR - Get Free Report) last issued its earnings results on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.46 by ($0.03). Integer had a return on equity of 11.65% and a net margin of 6.92%. The firm had revenue of $449.50 million during the quarter, compared to analyst estimates of $446.28 million. As a group, equities analysts predict that Integer Holdings Co. will post 6.01 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Integer

Several institutional investors and hedge funds have recently added to or reduced their stakes in ITGR. Mather Group LLC. grew its stake in shares of Integer by 304.3% in the fourth quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider's stock worth $25,000 after purchasing an additional 143 shares during the last quarter. Lee Danner & Bass Inc. acquired a new position in Integer during the 4th quarter worth about $27,000. AdvisorNet Financial Inc bought a new stake in shares of Integer in the 1st quarter valued at about $28,000. R Squared Ltd acquired a new stake in shares of Integer in the fourth quarter valued at about $44,000. Finally, Sterling Capital Management LLC raised its position in shares of Integer by 472.9% during the fourth quarter. Sterling Capital Management LLC now owns 338 shares of the medical equipment provider's stock worth $45,000 after acquiring an additional 279 shares during the last quarter. 99.29% of the stock is currently owned by institutional investors and hedge funds.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.